Rotigotine Effects on Bladder Function in Patients with Parkinson's Disease.

Area of Science:

• Neuroscience
• Urology
• Pharmacology

Background:

• Urinary urgency is a common and distressing symptom in Parkinson's disease (PD).
• Current treatments for PD-related bladder dysfunction are limited.
• Investigating the effects of dopaminergic agents on bladder function is crucial.

Purpose of the Study:

• To evaluate the efficacy of rotigotine treatment on bladder function in patients with Parkinson's disease and urinary urgency.
• To assess changes in urodynamic parameters and lower urinary tract symptoms.

Main Methods:

• A study involving 20 Parkinson's disease patients undergoing urodynamic evaluation.
• Patients completed International Prostate Symptoms questionnaires before and after 3 months of rotigotine patch monotherapy.
• Motor function was assessed using the Unified Parkinson Disease Rating Scale, Part III.

Main Results:

• Rotigotine significantly improved bladder filling sensation, detrusor overactivity thresholds, and bladder capacity.
• Patients reported a significant decrease in irritative urinary symptoms on the International Prostate Symptoms questionnaire.
• Improvements in bladder function were observed compared to the off-treatment condition.

Conclusions:

• Rotigotine demonstrates positive effects on bladder function in Parkinson's disease patients.
• The benefits may stem from rotigotine's balanced D1 and D2 receptor agonism, particularly D1 stimulation in brain regions regulating bladder control.
• Rotigotine offers a promising therapeutic option for managing urinary urgency in Parkinson's disease.